Neurobiology of diabetic encephalopathy

Drugs of the Future

Volumn 33, Issue 9, 2008, Pages 763-775

  Kuhad, Anurag ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; ALPHA TOCOPHEROL; AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; C PEPTIDE; CURCUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE B; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANXIETY DISORDER; BRAIN DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEMORY CONSOLIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STROKE;

EID: 60749098486     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2008.033.09.1232462     Document Type: Review

References (170)

1. King, H., Aubert, R.E., Herman, W.H. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998, 21(9): 1414-31.
2. American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care 2007, 30(Suppl. 1): S4-41.
3. Northam, E.A., Rankins, D., Cameron, F.J. Therapy insight The impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2006, 2(2): 78-86.
4. Brismar, T., Maurex, L., Cooray, G. et al. Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology 2007, 32(8-10): 1041-51.
5. Reske-Nielsen, E., Svendsen, K., Sogaard, H. Cerebral emboli as a result of "mute" juvenile endocarditis. Acta Pathol Microbiol Scand 1965, 63: 321-32.
6. Mijnhout, G.S., Scheltens, P., Diamant, M. et al. Diabetic encephalopathy: A concept in need of a definition. Diabetologia 2006, 49(6): 1447-8.
7. Olefsky, J.M. The insulin receptor: A multifunctional protein. Diabetes 1990, 39(9): 1009-16.
8. Adamo, M., Raizada, M.K., LeRoith, D. Insulin and insulin-like growth factor receptors in the nervous system. J Mol Neurobiol 1989, 3(1-2): 71-100.
9. Myers, M.G., White, M.F. The new elements of insulin signaling: Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 1993, 42(5): 643-50.
10. Avruch, J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 1999, 182(1-2): 31-48.
11. Unger, J., McNeill, T.H., Moxley, R.T., White, M., Moss, A., Livingston, J.N. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989, 31(1): 143-57.
12. Unger, J.W., Livingston, J.N., Moss, A.M. Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects. Prog Neurobiol 1991, 36(5): 343-62.
13. Craft, S., Watson, G.S. Insulin and neurodegenerative disease: Shared and specific mechanisms. Lancet Neurol 2004, 3(3): 169-78.
14. McIntyre, R.S., Soczynska, J.K., Woldeyohannes, H.O. et al. Thiazolidinediones: Novel treatments for cognitive deficits in mood disorders? Expert Opin Pharmacother 2007, 8(11): 1615-28.
15. Mcewen, B.S., Magarinos, A.M., Reagan, L.P. Studies of hormone action in the hippocampal formation: Possible relevance to depression and diabetes. J Psychosom Res 2002, 4(53): 883-90.
16. Shapiro, E., Brown, S.D., Saltiel, A.R. et al. Short-term action of insulin on Aplysia neurons: Generation of a possible novel modulator of ion channels. J Neurobiol 1991, 1(22): 55-62.
17. Masters, B.A., Shemer, J., Judkins, J.H. et al. Insulin receptors and insulin action in dissociated brain cells. Brain Res 1987, 2(417): 247-56.
18. Shibata, S., Liou, S.Y., Ueki, S. et al. Inhibitory action of insulin on suprachiasmatic nucleus neurons in rat hypothalamic slice preparations. Physiol Behav 1986, 1(36): 79-81.
19. Moosavi, M., Naghdi, N., Choopani, S. Intra CA1 insulin microinjection improves memory consolidation and retrieval. Peptides 2007, 28(5): 1029-34.
20. Babri, S., Badie, H.G., Khamenei, S., Seyedlar, M.O. Intrahippocampal insulin improves memory in a passive-avoidance task in male Wistar rats. Brain Cognition 2007, 64(1): 86-91.
21. Park, C.R. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001, 25(4): 311-23.
22. Reger, M.A., Watson, G.S., Green, P.S. et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008, 70(6): 440-8.
23. Reger, M.A., Watson, G.S., Green, P.S. et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 2008, 13(3): 323-31.
24. Benedict, C., Kern, W., Schultes, B., Born, J., Hallschmid, M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab 2008, 93(4): 1339-44.
25. Zhao, W.Q., Chen, H., Quon, M.J., Alkon, D.L. Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 2004, 490(1-3): 71-81.
26. Folli, F., Bonfanti, L., Renard, E., Kahn, C.R., Merighi, A. Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 1994, 4(11, Pt. 1): 6412-22.
27. Montagnani, M., Chen, H., Barr, V.A., Quon, M.J. Insulin-stimulated activation of eNDS is independent of Ca2 + but requires phosphorylation by Akt at Ser (1179). J Biol Chem 2001, 276(3): 30392-8.
28. Vincent, M.A., Montagnani, M., Quon, M.J. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003, 3(4): 279-88.
29. Montagnani, M., Ravichandran, L.V., Chen, H., Esposito, D.L., Quon, M.J. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothellal cells. Mol Endocrinol 2002, 16(8): 1931-42.
30. Zeng, G., Quon, M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996, 98(4): 894-8.
31. Zeng, G., Nystrom, F.H., Ravichandran, L.V., Cong, L.N., Kirby, M., Mostowski, H., Quon, M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101 (13): 1539-45.
32. Biessels, G.J., Kamal, A., Urban, I.J., Spruijt, B.M., Erkelens, D.W., Gispen, W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Effects of insulin treatment. Brain Res 1998, 800(1): 125-35.
33. Paulsen, O., Moser, E.I. A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 1998, 21(7): 273-8.
34. Choopani, S., Moosavi, M., Naghdi, N. Involvement of nitric oxide in insulin induced memory improvement. Peptides 2008, 29(6): 898-903.
35. Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 2006, 5(1): 64-74.
36. Brands, A.M.A., Kessels, R.P.C., Haana, E.H.F., Kappelle, L.J., Biessels, G.J. Cerebral dysfunction in type 1 diabetes: Effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 2004, 490(1-3): 159-68.
37. Banks, W.A., Jaspan, J.B., Kastin, A.J. Selective, physiological transport of insulin across the blood-brain barrier: Novel demonstration by species-specific radioimmunoassays. Peptides 1997, 18(8): 1257-62.
38. Baskin, D.G., Stein, L.J., Ikeda, H. et al. Genetically obese Zucker rats have abnormally low brain insulin content. Life Sci 1985, 36(7): 627-33.
39. Havrankova, J., Roth, J., Brownstein, M.J. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest 1979, 64(2): 636-42.
40. Marks, J.L., Eastman, C.J. Effect of starvation on insulin receptors in rat brain. Neuroscience 1989, 30(2): 551-6.
41. Figlewicz, D.P., Dorsa, D.M., Stein, L.J. et al. Brain and liver insulin binding is decreased in Zucker rats carrying the 'fa' gene. Endocrinology 1985, 117(4): 1537-43.
42. Pedersen, O., Beck-Nielsen, H. Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care 1987, 10(4): 516-23.
43. Miyazaki, Y., He, H., Mandarino, L.J., DeFronzo, R.A. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. Diabetes 2003, 52(8): 1943-50.
44. Messier, C., Teutenberg, K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast 2005, 12(4): 311-28.
45. Grunblatt, E., Salkovic-Petrisic, M., Osmanovic, J., Riederer, P., Hoyer, S. Brain insulin system dysfunction in streptozotocin intracerebroveritricutarty treated rats generates hyperphosphorylated tau protein. J Neurochem 2007, 101(3): 757-70.
46. Alafuzoff, I., Aho, L., Helisalmi, S., Mannermaa, A., Soininen, H. β-Amyloid deposition in brains of sublects with diabetes. Neuropathol Appl Neurobiol 2008.
47. Dou, J.T., Chen, M., Dufour, F., Alkon, D.L., Zhao, W.Q. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem 2005, 12(6): 646-55.
48. Levy, Y.S., Gilgun-Sherki, Y., Melamed, E., Offen, D. Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs 2005, 19(2): 97-127.
49. Offen, D., Shtaif, B., Hadad, D., Weizman, A., Melamed, E., Gil-Ad, I. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: Possible implications for Parkinson's disease. Neurosci Lett 2001, 316(3): 129-32.
50. Barinaga, M. Neurotrophic factors enter the clinic. Science 1994, 264(5160): 772-4.
51. Schneider, H.J., Pagotto, U., Stalla, G.K. Central effects of the somatotropic system. Eur J Endocrinol 2003, 149(5): 377-92.
52. Bohannon, N.J., Corp, E.S., Wilcox, B.J., Figlewicz, D.P., Dorsa, D.M., Baskin, D.G. Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res 1988, 444(2): 205-13.
53. Araujo, D.M., Lapchak, P.A., Collier, B., Chabot, J.G., Quirion, R. Insulin-like growth-factor-1 (somatomedin-C) receptors in the rat brain: Distribution and interaction with the hippocampal cholinergic system. Brain Res 1989, 484(1-2): 130-8.
54. Adem, A., Jossan, S.S., d'Argy, A., Gillberg, P.G., Nordberg, A., Winblad, B., Sara, V. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: Quantitative autoradiographic localization. Brain Res 1989, 503(2): 299-303.
55. Carro, E., Trejo, J.L., Gerber, A., Loetscher, H., Torrado, J., Metzger, F., Torres-Aleman, I. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol Aging 2006, 27(9): 1250-7.
56. Carro, E., Trejo, J.L., Gomez-Isla, T., LeRoith, D., Torres-Aleman, I. Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat Med 2002, 8(12): 1390-7.
57. Aleman, A., Verhaar, H.J., De Haan, E.H. et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 1999, 84(2): 471-5.
58. Rollero, A., Murialdo, G., Fonzi, S. et al. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology 1998, 38(2): 73-9.
59. Morley, J.E., Kaiser, F., Raum, W.J. et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor I to growth hormone. Proc Natl Acad Sci USA 1997, 94(14): 7537-42.
60. Paolisso, G., Ammendola, S., Del Buono, A. et al. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 1997, 82(7): 2204-9.
61. Papadakis, M.A., Grady, D., Tierney, M.J., Black, D., Wells, L., Grunfeld, C. Insulin-like growth factor 1 and functional status in healthy older men. J Am Geriatr Soc 1995, 43(12): 1350-5.
62. Dik, M.G., Pluijm, S.M., Jonker, C., Deeg, D.J., Lomecky, M.Z., Lips, P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol Aging 2003, 24(4): 573-81.
63. Kalmijn, S., Janssen, J.A., Pols, H.A., Lamberts, S.W., Breteler, M.M. A prospective study on circulating insulin-like growth factor-I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 2000, 85(12): 4551-5.
64. Sonntag, W.E., Ramsey, M., Carter, C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 2005, 4(2): 195-212.
65. Landi, F., Russo, A., Capoluongo, E. et al. Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community. Int Hematol 2007, 85(4): 294-9.
66. Elias, M.F., Beiser, A., Wolf, P.A., Au, R., White, R.F., D'Agostino, R.B. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 2000, 57(6): 808-13.
67. Brookmeyer, R., Gray, S., Kawas, C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88(9): 1337-42.
68. Brass, B.J., Nonner, D., Barrett, J.N. Differential effects of insulin on choline acetyltransferase and glutamic acid decarboxylase activities in neuron-rich striatal cultures. J Neurochem 1992, 59(2): 415-24.
69. Kar, S., Seto, D., Dore, S., Hanisch, U., Quirion, R. Insulin-like growth factors-I and II differentially regulate endogenous acetylcholine release from the rat hippocampus. Proc Natl Acad Sci USA 1997, 94(25): 14054-9.
70. Blair, L.A.C., Marshall, J. IGF-I modulates N and L calcium channels in a PI-3-kinase-dependent manner. Neuron 1997, 19(2): 421-9.
71. Tsukahara, H., Gordienko, D.V., Tonshoff, B., Gelato, M.C., Goligorsky, M.S. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994, 45(2): 598-604.
72. Zorumski, C.F., Izumi, Y. Nitric oxide and hippocampal synaptic plasticity. Biochem Pharmacol 1993, 46(5): 777-85.
73. Markowska, A.L., Mooney, M., Sonntag, W.E. Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience 1998, 87(3): 559-69.
74. Arwert, L.I., Veltman, D.J., Deijen, J.B., Lammertsma, A.A., Jonker, C., Drent, M.L. Memory performance and the growth hormone/insulin-like growth factor axis in elderly: A positron emission tomography study. Neuroendocrinology 2005, 81(1): 31-40.
75. Yamada, K., Nabeshima, T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 2003, 91(4): 267-70.
76. Castro-Alamancos, M.A., Torres-Aleman, I. Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonucleotide. Proc Natl Acad Sci USA 1994, 91(21): 10203-7.
77. Grunblatt, E., Hoyer, S., Riederer, P. Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease. J Neural Transm 2004, 111(3): 367-86.
78. Wuarin, L., Namdev, R., Burns, J.G., Fei, Z.J., Ishii, D.N. Brain insulin-like growth factor-II mRNA content is reduced in insulin-dependent and non-insulin-dependent diabetes mellitus. J Neurochem 1996, 67(2): 742-51.
79. Li, Z.G., Zhang, W., Grunberger, G., Sima, A.A.F. Hippocampal neuronal apoptasis in type 1 diabetes. Brain Res 2002, 946(2): 221-31.
80. Sima, A.F.A., Kamiya, H., Li, Z.G. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004, 490(1-3): 187-97.
81. Sima, A.A. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 2003, 60(11): 2445-64.
82. Sima, A.A. C-peptide and diabetic neuropathy. Expert Opin Investig Drugs 2003, 12(9): 1471-88.
83. Zierath, J.R., Galuska, D., Johansson, B.L., Wallberg-Henriksson, H. Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle. Diabetologia 1991, 34(12): 899-901.
84. Zierath, J.R., Handberg, A., Tally, M., Wallberg-Henriksson, H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 1996, 39(3): 306-13.
85. Johansson, B.L., Linde, B., Wahren, J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 1992, 35(12): 1151-8.
86. Johansson, B.L., Borg, K., Fernqvist-Forbes, E., Odergren, T., Remahl, S., Wahren, J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996, 39(6): 687-95.
87. Forst, T., Kunt, T., Pfutzner, A., Beyer, J., Wahren, J. New aspects on biological activity of C-peptide in IDDM patients. Exp Clin Endocrinol Diabetes 1998, 106(4): 270-6.
88. Fernqvist-Forbes, E., Johansson, B.L., Eriksson, M.J. Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus. Acta Physiol Scand 2001, 172(3): 159-65.
89. Wu, W., Oshida, Y., Yang, W.P. et al. Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats. Acta Physiol Scand 1996, 157(2): 253-8.
90. Ido, Y., Vindigni, A., Chang, K. et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997, 277(5325): 563-6.
91. Li, L., Oshida, Y., Kusunoki, M., Yamanouchi, K., Johansson, B.L., Wahren, J., Sato, Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 1999, 42(8): 958-64.
92. Samnegard, B., Jacobson, S.H., Jaremko, G., Johansson, B.L., Sjoquist, M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001, 60(4): 1258-65.
93. Zhang, W., Yorek, M., Pierson, C.R., Murakawa, Y., Breidenbach, A., Sima, A.A. Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat. Int J Exp Diabetes Res 2001, 2(3): 187-93.
94. Sima, A.A., Zhang, W., Sugimoto, K., Henry, D., Li, Z., Wahren, J., Grunberger, G. C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 2001, 44(7): 889-97.
95. Huang, D.Y., Richter, K., Breidenbach, A., Vallon, V. Human C-peptide acutely lowers glomerular hypertiltration and proteinuria in diabetic rats: A dose-response study. Naunyn Schmiedebergs Arch Pharmacol 2002, 365(1): 67-73.
96. Pierson, C.R., Zhang, W., Sima, A.A. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol 2003, 62(7): 765-79.
97. Sima, A.A., Li, Z.G. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 2005, 54(5): 1497-505.
98. Li, Z.G., Sima, A.A. C-peptide and central nervous system complications in diabetes. Exp Diabesity Res 2004, 5(1): 79-90.
99. Vannucci, S.J., Koehler-Stec, E.M., Li, K., Reynolds, T.H., Clark, R., Simpson, I.A. GLUT4 glucose transporter expression in rodent brain: Effect of diabetes. Brain Res 1998, 797(1): 1-11.
100. Duelli, R., Kuschinsky, W. Brain glucose transporters: Relationship to local energy demand. News Physiol Sci 2001, 16: 71-6.
101. El Messari, S., Ait-Ikhlef, A., Ambroise, D.H., Penicaud, L., Arluison, M. Expression of insulin-responsive glucose transporter GLUT4 mRNA in the rat brain and spinal cord: An in situ hybridization study. J Chem Neuroanat 2002, 24(4): 225-42.
102. Membrez, M., Hummler, E., Beermann, F., Haefliger, J.A., Savioz, R., Pedrazzini, T., Thorens, B. GLUT8 is dispensable for embryonic development but influences hippocampal neurogenesis and heart function. Mol Cell Biol 2006, 26(11): 4268-76.
103. Winocur, G., Moscovitch, M., Caruana, D.A., Binns, M.A. Retrograde amnesia in rats with lesions to the hippocampus on a test of spatial memory. Neuropsychologia 2005, 43(11): 1580-90.
104. de la Torre, J.C. Pathophysiology of neuronal energy crisis in Alzheimer's disease. Neurodegener Dis 2008, 5(3-4): 126-32.
105. Mankovsky, B.N., Patrick, J.T., Metzger, B.E., Saver, J.L. The size of subcortical ischemic infarction in patients with and without diabetes mellitus. Clin Neurol Neurosurg 1996, 98(2): 137-41.
106. Beckman, J.A., Creager, M.A., Libby, P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002, 287(19): 2570-81.
107. Frost, D., Beischer, W. Determinants of carotid artery wall thickening in young patients with type 1 diabetes mellitus. Diabetes Med 1998, 15(10): 851-7.
108. Frost, D., Beischer, W. Progression of the carotid artery intima-media thickness in young patients with type 1 diabetes. Diabetes Care 2003, 26(2): 545.
109. Johnson, P.C., Brendel, K., Meezan, E. Thickened cerebral cortical capillary basement membranes in diabetics. Arch Pathol Lab Med 1982, 106(5): 214-7.
110. Keymeulen, B., Jacobs, A., de Metz, K., de Sadeleer, C., Bossuyt, A., Somers, G. Regional cerebral hypoperfusion in long-term type 1 (insulin-dependent) diabetic patients: Relation to hypoglycaemic events. Nucl Med Commun 1995, 16(1): 10-6.
111. Rodriguez, G., Nobili, F., Celestino, MA. et al. Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care 1993, 16(2): 462-8.
112. Grill, V., Gutniak, M., Bjorkman, O. et al. Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol 1990, 258(5, Pt. 1): E813-20.
113. Sabri, O., Hellwig, D., Sohreckenberger, M. et al. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 2000, 21(1): 19-29.
114. Sredy, J., Sawicki, D.R., Notvest, R.R. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: Effect of dietary galactose withdrawal or tolrestat intervention therapy. J Diabet Complications 1991, 5(1): 42-7.
115. Knudsen, G.M., Jakobsen, J. Barry, D.I., Compton, A.M., Tomlinson, D.R. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience 1989, 29(3): 773-7.
116. Aszalos, Z. Cerebral complications of diabetes mellitus. Orv Hetil 2007, 148(50): 2371-6.
117. Brownlee, M. Negative consequences of glycation. Metabolism 2000, 49(2, Suppl. 1): 9-13.
118. Singh, L.P., Gennerette, D., Simmons, S., Crook, E.D. Glucose-induced insulin resistance of phosphatidylinositol 3′-OH kinase and AKT/ PKB is mediated by the hexosamine biosynthesis pathway. J Diabet Complications 2001, 15(2): 88-96.
119. Vlassara, H., Brownlee, M., Cerami, A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 1983, 32(7): 670-4.
120. Ryle, C., Leow, C.K., Donaghy, M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 1997, 20(5): 577-84.
121. Vitek, M.P., Bhattacharya, K., Glendening, J.M. et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994, 91(11): 4766-70.
122. Munch, G., Apelt, J., Rosemarie-Kientsch-Engel, Stahl, P., Luth, H.J., Schliebs, R. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology. J Neurochem 2003, 86(2): 283-9.
123. Araki, A., Murotani, Y., Kamimiya, F., Ito, H. Low well-being is an independent predictor for stroke in elderly patients with diabetes mellitus. J Am Geriatr Soc 2004, 52(2): 205-10.
124. Aragno, M., Mastrocola, R., Medana, C. et al. Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology 2005, 146(12): 5561-7.
125. Mastrocola, R., Restivo, F., Vercellinatto, I., Danni, O., Brignardello, E., Aragno, M., Boccuzzi, G. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005, 187(1): 37-44.
126. Nishikawa, T., Edelstein, D., Du, XL. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404(6779): 787-90.
127. Bonnefont-Rousselot, D. Glucose and reactive oxygen species. Curr Opin Olin Nutr Metab Care 2002, 5(5): 561-8.
128. Evans, J.L., Goldfine, I.D., Maddux, B.A., Grodsky, G.M. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23(5): 599-622.
129. Aragno, M., Parola, S., Tamagno, E., Brignardello, E., Manti, R., Danni, O., Boccuzzi, G. Oxidative derangement in rat synaptosomes induced by hyperglycaemia: Restorative effect of dehydroepiandrosterone treatment. Biochem Pharmacol 2000, 60(3): 389-95.
130. Aragno, M., Mastrocola, R., Brignardello, E. et al. Dehydroepiandrosterone modulates nuclear factor-kB activation in hippocampus of diabetic rats. Endocnnology 2002, 143(9): 3250-8.
131. Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., Bennett, D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004, 61(5): 661-6.
132. Kuhad, A., Chopra, K. Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res 2008,185(3): 411-20.
133. Kuhad, A., Chopra, K. Curcumin attenuates diabetic encephalopathy in rats: Behavioral and biochemical evidences. Eur J Pharmacol 2007, 576(1-3): 34-42.
134. Fukui, M., Kitagawa, Y., Nakamura, N., Yoshikawa, T. Adult-onset type 1 diabetes with DIDMOAD syndrome-like manifestations. Arch Intern Med 2001, 161(5): 767-8.
135. Baydas, G., Canatan, H., Turkoglu, A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002, 32(4): 225-30.
136. Hawkins, C.L., Davies, M.J. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001, 1504(2-3): 196-219.
137. Kumar, J.S., Menon, V.P. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993, 42(11): 1435-9.
138. Ramakrishnan, R., Kempuraj, D., Prabhakaran, K. et al. A short-term diabetes induced changes of catecholamines and p38-MAPK in discrete areas of rat brain. Life Sci 2005, 77(15): 1825-35.
139. Rossi, G.L., Bestetti, G. Morphological changes in the hypothalamic-hypophyseal-gonadal axis of male rats after twelve months of streptozotocin-induced diabetes. Diabetologia 1981, 21(5): 476-81.
140. Reske-Nielsen, E., Lundbaek, K. Diabetic encephalopathy. Diffuse and focal lesions of the brain in long-term diabetes. Acta Neurol Scand Suppl 1963, 39(4): 273-90.
141. Bitar, M., Koulu, M., Rapoport, S.I., Linnoila, M. Diabetes-induced alteration in brain monoamine metabolism in rats. J Pharmacol Exp Ther 1986, 236(2): 432-7.
142. Tasaka, Y., Matsumoto, H., Inoue, Y., Hirata, Y. Brain catecholamine concentrations in hyperosmolar diabetic and diabetic rats. Diabetes Res 1992, 19(1): 1-7.
143. Trulson, M.E., Himmel, CD. Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats. J Neurochem 1985, 44(6): 1873-6.
144. Ragozzino, M.E., Unick, K.E., Gold, P.E. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose. Proc Natl Acad Sci USA 1996, 93(10): 4693-8.
145. Ragozzino, M.E., Pal, S.N., Unick, K., Stefani, M.R., Gold, P.E. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. J Neurosci 1998, 18(4): 1595-601.
146. Hajnal, A., Pathos, E.N., Lenard, L., Hoebel, B.G. Effects of feeding and insulin on extracellular acetylcholine in the amygdala of freely moving rats. Brain Res 1998, 785(1): 41-8.
147. Bhattacharya, S.K., Saraswati, M. Effect on intracerebroventricularly administered insulin on brain monoamines and acetylcholine in euglycaemic and alloxan-induced hyperglycaemic rats. Indian J Exp Biol 1991, 29(12): 1095-100.
148. Messier, C., Destrade, C. Insulin attenuates scopolamine-induced memory deficits. Psychobiology 1994, 22: 16-21.
149. Kopf, S.R., Baratti, G.M. The impairment of retention induced by insulin in mice may be mediated by a reduction in central cholinergic activity. Neurobiol Learn Mem 1995, 63(3): 220-8.
150. Gold, P.E. Role of glucose in regulating the brain and cognition. Am J Clin Nutr 1995, 61(4, Suppl.): 987S-95S.
151. Chen, C.C., Liu, I.M. Release of acetylcholine by Hon-Chi to raise insulin secretion in Wistar rats. Neurosci Lett 2006, 404(1-2): 117-21.
152. Hsu, J.H., Wu, Y.C., Liu, I.M., Cheng, J.T. Release of acetylcholine to raise insulin secretion in Wistar rats by oleanolic acid, one of the active principles contained in Cornus officinalis. Neurosci Lett 2006, 404(1-2): 112-6.
153. Su, C.F., Cheng, J.T., Liu, I.M. Increase of acetylcholine release by Panax ginseng root enhances insulin secretion in Wistar rats. Neurosci Lett 2007, 412(2): 101-4.
154. Trudeau, F., Gagnon, S., Massicotte, G. Hippocampal synaptic plasticity and glutamate receptor regulation: Influences of diabetes mellitus. Eur J Pharmacol 2004, 490(1-3): 177-86.
155. Liao, G.Y., Leonard, J.P. Insulin modulation of cloned mouse NMDA receptor currents in Xenopus oocytes. J Neurochem 1999, 73(4): 1510-9.
156. Chen, C., Leonard, J.P. Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors. J Neurochem 1996, 67(1): 194-200.
157. Skeberdis, V.A., Lan, J., Zheng, X., Zukin, R.S., Bennett, M.V. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci USA 2001, 98(6): 3561-6.
158. Christie, J.M., Wenthold, R.J., Monaghan, D.T. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. J Neurochem 1999, 72(4): 1523-8.
159. Huerta, P.T., Sun, L.D., Wilson, M.A., Tonegawa, S. Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 2000, 25(2): 473-80.
160. Nakazawa, K., Quirk, M.C., Chitwood, R.A. et al. Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science 2002, 297(5579): 211-8.
161. Wu, G., Malinow, R., Cline, H.T. Maturation of a central glutamatergic synapse. Science 1996, 274(5289): 972-6.
162. Renger, J.J., Egles, C., Liu, G. A developmental switch in neurotransmitter flux enhances synaptic efficacy by affecting AMPA receptor activation. Neuron 2001, 29(2): 469-84.
163. Malinow, R. AMPA receptor trafficking and long-term potentiation. Philos Trans R Soc Lond B Biol Sci 2003, 358(1432): 707-14.
164. Malinow, R., Mainen, Z.F., Hayashi, Y. LTP mechanisms: From silence to four-lane traffic. Curr Opin Neurobiol 2000, 10(3): 352-7.
165. Plitzko, D., Rumpel, S., Gottmann, K. Insulin promotes functional induction of silent synapses in differentiating rat neocortical neurons. Eur J Neurosci 2001, 14(8): 1412-5.
166. Man, H.Y., Lin, J.W., Ju, W.H. et al. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 2000, 25(3): 649-62.
167. Chapouthier, G., Venault, P. GABA-A receptor complex and memory processes. Curr Top Med Chem 2002, 2(8): 841-51.
168. McGaugh, J.L. Memory consolidation and the amygdala: A systems perspective. Trends Neurosci 2002, 25(9): 456.
169. Wan, Q., Xiong, Z.G., Man, H.Y. et al. Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 1997, 388(6643): 686-90.
170. Ma, X.H., Zhong, P., Gu, Z., Feng, J., Yan, Z. Muscarinic potentiation of GABA(A) receptor currents is gated by insulin signaling in the prefrontal cortex. J Neurosci 2003, 23(4): 1159-68.